Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 16 | Issue 1 | 2026 | pp. 167–173Open access
A Novel Eco-Compatible Green UV-Spectroscopic Analytical Method Development and Validation for Apremilast Estimation in Bulk, Marketed Formulation and in Nanovesicles
- 1,
- 2*
- 1 Department of Pharmaceutics, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Nehru Nagar, Belagavi, Karnataka, INDIA.
- 2 Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Nehru Nagar, Belagavi, Karnataka, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Sunil Satyappa Jalalpure
Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Nehru Nagar, Belagavi, Karnataka, INDIA.
Email: jalalpuresunil@rediffmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- Received:
- May 6, 2025
- Accepted:
- Sep 29, 2025
- DOI:
- 10.5530/ijpi.20260513
How to cite
Sutar, K. P., & Jalalpure, S. S. (2026). A Novel Eco-Compatible Green UV-Spectroscopic Analytical Method Development and Validation for Apremilast Estimation in Bulk, Marketed Formulation and in Nanovesicles. International Journal of Pharmaceutical Investigation, 16(1), 167–173. https://doi.org/10.5530/ijpi.20260513
Abstract
Background
The proposed study focuses on developing and validating a sensitive and simple UV-spectroscopic technique for apremilast quantification in bulk drug, commercial tablet, cubosomes and transferosomes.
Materials and Methods
The optimum conditions for analysing apremilast were developed with methanol and phosphate buffer pH 6.8. It shows maximum absorbance at 230nm wavelength. QC standards were used for determining several validation parameters for analytical methods, including accuracy, precision, LOD, LOQ, robustness and ruggedness. In accordance to ICH Q2 (R1) guidelines, the validated technique was applied to quantify apremilast in commercial tablets, bulk, cubosomes and transferosomes.
Results and Discussion
Apremilast exhibited a maximum absorption at a wavelength of 230 nm. Calibration curve was plotted at concentration ranging from 0.2-1.0 µg/mL, with linear equation of y = 0.8017x + 0.0105 and coefficient of variance was observed to be 0.998. The detection limits and quantification limits were found to be 0.09 µg/mL and 0.28 µg/mL respectively. Repeatability and precision results were within (2%) acceptable ranges. Apremilast recovery in marketed formulations, cubosomes and in transferosomes was found to be between 100.47%, 99.97% and 98.35 respectively.
Conclusion
The proposed analytical technique was observed to be novel, eco-friendly, reliable and precise for quantifying apremilast in bulk, commercial tablets, cubosomes and transferosomes. It can be used in the pharmaceutical industry for apremilast in various formulations.
Keywords
Subject
Article metadata
| Title | A Novel Eco-Compatible Green UV-Spectroscopic Analytical Method Development and Validation for Apremilast Estimation in Bulk, Marketed Formulation and in Nanovesicles |
|---|---|
| Authors | Kishori Prasanna Sutar; Sunil Satyappa Jalalpure |
| Affiliations | Department of Pharmaceutics, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Nehru Nagar, Belagavi, Karnataka, INDIA.; Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Nehru Nagar, Belagavi, Karnataka, INDIA. |
| Corresponding author | jalalpuresunil@rediffmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 16, Issue 1 (2026) |
Also in this issue
- Anti-Parkinson Drug Levodopa: It's Novel Delivery Systems, Preclinical and Clinical Studies: A Reviewpp. 1–11
- Shifting Regulatory Frameworks for Nanomedicine in the Evolution of Personalized Medicinepp. 12–22
- A Global Perspective on Navigating the Regulatory Landscape of Adaptive AI in Healthcare: Balancing Innovation and Patient Safetypp. 23–29
- Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Reviewpp. 30–42
- The Empowerment of Drugs Inspectors Under the Drugs and Cosmetics Act, 1940-A Review of Implementation of Power of Arrest Conferred by Hon’ble Supreme Court of Indiapp. 43–50